Cti Biopharma Stock Price, News & Analysis
Company Description
Cti Biopharma (NASDAQ: CTIC) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.2B.
CTIC stock has declined 100.0% over the past year.
This page provides a comprehensive overview of CTIC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cti Biopharma (CTIC) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.2B, CTIC is classified as a small-cap stock with approximately 131.9M shares outstanding.
Latest News
Cti Biopharma has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, conferences, earnings. View all CTIC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CTIC Company Profile & Sector Positioning
Cti Biopharma (CTIC) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.